Our "financial" position is similar to what it was previously, as far as anyone knows at this moment-no product being sold, no grant announced, and no deal announced. As of this time.
And that could change at any moment. Our "position" is vastly different than it was a year ago, thanks to the progress that had been made on B for IBD and the current push for use on covid. Very good soft bashing, IMO. Ignore function works well and makes this board much better to read.